Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

BA-BE Studies: SOP for Review of Instrument Calibration Logs – V 2.0

Posted on By

BA-BE Studies: SOP for Review of Instrument Calibration Logs – V 2.0

Standard Operating Procedure for Review of Instrument Calibration Logs in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/200/2025
Supersedes SOP/BA-BE/200/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define the procedure for reviewing instrument calibration logs to ensure that all analytical equipment used in bioanalytical studies for BA/BE trials is accurately calibrated and meets performance requirements prior to use.

2. Scope

This SOP applies to all calibration logs of critical analytical instruments including HPLC, LC-MS/MS, balances, pH meters, and centrifuges used in the bioanalytical laboratory for BA/BE

studies.

3. Responsibilities

  • Analyst/Technician: Performs and records calibration data in the logbook.
  • QA Officer: Verifies calibration completeness and compliance with SOP.
  • Lab Supervisor: Reviews calibration data for validity and signs off.
See also  BA-BE Studies: SOP for Ethics Committee Submission Requirements - V 2.0

4. Accountability

The Head of the Bioanalytical Department is accountable for ensuring that no analytical activity is performed using uncalibrated or non-compliant equipment.

5. Procedure

5.1 Calibration Log Maintenance

  1. Each instrument shall have a dedicated calibration logbook or electronic log (Annexure-1).
  2. Logbook entries must include:
    • Calibration date
    • Parameters checked
    • Observed values
    • Acceptance range
    • Deviation (if any)
    • Initials and signature

5.2 Review Frequency

  1. Review instrument calibration logs:
    • Monthly for high-frequency use instruments (e.g., LC-MS/MS)
    • Quarterly for support equipment (e.g., balances, pH meters)
  2. Conduct additional reviews:
    • Before study initiation
    • During audits or inspections
    • Following any instrument malfunction

5.3 Review Process

  1. Cross-check the calibration dates against due dates and SOP schedules.
  2. Verify:
    • Calibration was performed within schedule
    • All parameters meet acceptance criteria
    • No data overwriting or missing entries
  3. Highlight discrepancies and incomplete calibrations in the Calibration Review Summary (Annexure-2).
See also  BA-BE Studies: SOP for Preparing for GCP Inspections and Audit Readiness - V 2.0

5.4 Handling Deviations

  1. If calibration is overdue:
    • Label equipment as “Out of Service”
    • Inform the Lab Head and QA
    • Prevent usage until recalibrated
  2. If calibration results are out of specification:
    • Stop equipment use
    • Log deviation in Deviation Register
    • Investigate root cause and initiate corrective actions

5.5 Documentation

  1. Ensure every review entry includes:
    • Reviewer name
    • Date of review
    • Comments
    • Signature
  2. Maintain reviewed logs in the equipment calibration file for 5 years.

6. Abbreviations

  • BA/BE: Bioavailability/Bioequivalence
  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • HPLC: High-Performance Liquid Chromatography
  • LC-MS/MS: Liquid Chromatography with Tandem Mass Spectrometry

7. Documents

  1. Instrument Calibration Logbook – Annexure-1
  2. Calibration Review Summary – Annexure-2
See also  BA-BE Studies: SOP for Blinding and Unblinding Protocols in BA/BE Studies - V 2.0

8. References

  • ICH Q9: Quality Risk Management
  • OECD GLP Principles
  • 21 CFR Part 11 – Electronic Records & Signatures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Instrument Calibration Logbook

Instrument ID Date Parameter Observed Value Acceptance Range Performed By
LCMS-03 15/03/2025 Retention Time 2.52 min 2.5 ± 0.2 Ajay Verma

Annexure-2: Calibration Review Summary

Date Instrument ID Reviewer Compliance Remarks
17/04/2025 LCMS-03 Sunita Reddy Yes All parameters within limits

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP New implementation QA Head
17/04/2025 2.0 Updated review frequency and deviation control steps Audit recommendation QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: Aerosol: SOP for Ensuring Regulatory Compliance in Aerosol Product Development – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Cleaning and Maintenance of HEPA Filters in Cleanrooms – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version